Zoloft is in shortage
More evidence that the pandemic is taking a toll on both mental health and the supply chains: the U.S. is facing a pandemic-induced shortage of the antidepressant Zoloft. Bloomberg reports that, on Friday, the Food and Drug Administration added Zoloft to its drug shortage list, which shows that pharmaceutical companies have reported both increased demand and inability to obtain an active ingredient.
